| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 26% | -14% | $427,376,736 | 31,424,760 | 0% | GILEAD SCIENCES, INC. | 03 Nov 2025 | |
| BlackRock, Inc. | 10% | +11% | $303,514,602 | +$65,766,227 | 12,736,927 | +28% | BlackRock, Inc. | 31 Dec 2025 |
| Point72 Asset Management, L.P. | 4.1% | -28% | $58,921,714 | -$20,381,232 | 4,332,479 | -26% | Point72 Asset Management, L.P. | 30 Sep 2025 |
As of 30 Sep 2025, 185 institutional investors reported holding 100,610,225 shares of Arcus Biosciences, Inc. - Common Stock (RCUS). This represents 82% of the company’s total 122,470,452 outstanding shares.
The largest institutional shareholders of Arcus Biosciences, Inc. - Common Stock (RCUS) together control 72% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 26% | 31,424,760 | 0% | 24% | $427,376,736 |
| BlackRock, Inc. | 9.6% | 11,810,866 | +3.1% | 0% | $160,627,778 |
| VANGUARD GROUP INC | 5.4% | 6,629,453 | +1.1% | 0% | $90,160,561 |
| Point72 Asset Management, L.P. | 3.5% | 4,332,479 | -27% | 0.13% | $58,921,714 |
| Woodline Partners LP | 3.1% | 3,769,684 | -5.8% | 0.24% | $51,267,702 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3% | 3,688,858 | 0% | 1.5% | $50,168,469 |
| STATE STREET CORP | 2.8% | 3,394,854 | -6.5% | 0% | $46,170,014 |
| Siren, L.L.C. | 2.4% | 2,912,077 | +81% | 1.5% | $39,604,247 |
| FMR LLC | 1.9% | 2,296,021 | -11% | 0% | $31,225,884 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3% | 1,598,409 | +0.13% | 0% | $21,740,690 |
| MORGAN STANLEY | 1.3% | 1,536,088 | +4.5% | 0% | $20,890,796 |
| DIMENSIONAL FUND ADVISORS LP | 1.2% | 1,502,463 | -9.5% | 0% | $20,431,602 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.2% | 1,419,985 | +1.7% | 0.05% | $19,312,000 |
| BANK OF AMERICA CORP /DE/ | 1.1% | 1,360,781 | +173% | 0% | $18,506,622 |
| WELLINGTON MANAGEMENT GROUP LLP | 1% | 1,266,289 | +35% | 0% | $17,221,530 |
| Sofinnova Investments, Inc. | 1% | 1,222,263 | +0.51% | 1% | $16,622,777 |
| RA CAPITAL MANAGEMENT, L.P. | 0.93% | 1,136,364 | 0% | 0.19% | $15,454,550 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.91% | 1,120,062 | +39% | 0.06% | $15,232,843 |
| GOLDMAN SACHS GROUP INC | 0.78% | 950,589 | +47% | 0% | $12,928,010 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.71% | 871,150 | +12% | 0% | $11,847,640 |
| Fisher Asset Management, LLC | 0.6% | 729,153 | +727% | 0% | $9,916,480 |
| NORTHERN TRUST CORP | 0.58% | 707,796 | +2.4% | 0% | $9,626,027 |
| Parkman Healthcare Partners LLC | 0.53% | 652,680 | +8.9% | 0.97% | $8,876,448 |
| MILLENNIUM MANAGEMENT LLC | 0.52% | 634,944 | -19% | 0.01% | $8,635,238 |
| DAFNA Capital Management LLC | 0.51% | 627,626 | 0% | 2.1% | $8,535,714 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 529,216 | $12,601,047 | -$2,403,529 | $23.83 | 9 |
| 2025 Q3 | 100,610,225 | $1,368,169,061 | +$17,186,644 | $13.60 | 185 |
| 2025 Q2 | 99,735,332 | $811,386,525 | +$23,005,595 | $8.14 | 181 |
| 2025 Q1 | 97,195,653 | $762,981,433 | +$76,941,552 | $7.85 | 183 |
| 2024 Q4 | 83,908,968 | $1,249,338,646 | -$21,214,675 | $14.89 | 185 |
| 2024 Q3 | 53,324,923 | $815,463,718 | +$21,618,657 | $15.29 | 184 |
| 2024 Q2 | 51,955,193 | $791,285,512 | -$15,709,425 | $15.23 | 191 |
| 2024 Q1 | 52,828,671 | $997,275,069 | +$741,376 | $18.88 | 169 |
| 2023 Q4 | 52,818,611 | $1,008,878,346 | -$1,266,933 | $19.10 | 181 |
| 2023 Q3 | 52,811,112 | $947,947,087 | -$30,726,648 | $17.95 | 184 |
| 2023 Q2 | 54,702,646 | $1,110,123,478 | -$11,409,103 | $20.31 | 177 |
| 2023 Q1 | 55,490,875 | $1,012,137,432 | +$17,396,401 | $18.24 | 177 |
| 2022 Q4 | 53,808,832 | $1,112,728,096 | +$17,661,819 | $20.68 | 199 |
| 2022 Q3 | 52,505,739 | $1,373,608,654 | -$54,087 | $26.16 | 171 |
| 2022 Q2 | 52,444,913 | $1,329,092,467 | -$15,970,235 | $25.34 | 162 |
| 2022 Q1 | 50,609,470 | $1,598,261,880 | -$43,817,366 | $31.56 | 146 |
| 2021 Q4 | 50,826,972 | $2,056,609,533 | +$107,109,155 | $40.47 | 136 |
| 2021 Q3 | 48,251,727 | $1,682,950,642 | +$59,932,851 | $34.87 | 127 |
| 2021 Q2 | 45,147,112 | $1,239,729,813 | +$11,589,356 | $27.46 | 125 |
| 2021 Q1 | 44,736,322 | $1,254,917,338 | +$7,899,154 | $28.08 | 143 |
| 2020 Q4 | 44,575,673 | $1,157,187,273 | +$10,417,742 | $25.96 | 143 |
| 2020 Q3 | 44,391,126 | $760,991,949 | +$17,571,170 | $17.14 | 127 |
| 2020 Q2 | 41,840,912 | $1,034,233,021 | +$380,488,277 | $24.74 | 138 |
| 2020 Q1 | 26,992,583 | $374,653,368 | -$448,171 | $13.88 | 92 |
| 2019 Q4 | 23,560,774 | $237,962,351 | -$3,030,738 | $10.10 | 74 |
| 2019 Q3 | 25,809,690 | $234,896,496 | -$672,043 | $9.10 | 73 |
| 2019 Q2 | 26,440,928 | $210,047,107 | +$6,023,856 | $7.95 | 76 |
| 2019 Q1 | 25,799,127 | $322,227,437 | -$12,715,178 | $12.49 | 63 |
| 2018 Q4 | 26,918,679 | $289,911,060 | -$4,742,182 | $10.77 | 66 |
| 2018 Q3 | 22,437,315 | $312,774,356 | +$950,561 | $13.94 | 56 |
| 2018 Q2 | 22,392,855 | $274,091,081 | +$31,576,470 | $12.24 | 61 |
| 2018 Q1 | 16,255,471 | $250,516,107 | +$250,516,106 | $15.44 | 55 |